V
Veru Inc. (VERU)
NCM – Real vaqt narxi. Valyuta: USD
2.09
-0.14 (-6.28%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.09
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
2.09
-0.14 (-6.28%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.09
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:10 PM EDT
Veru Inc. kechki klinik bosqichdagi biofarmatsevtika kompaniyasi bo'lib, Florida va xalqaro miqyosda metabolik kasalliklar, onkologiya va viruslar keltirib chiqaradigan o'tkir respirator distress sindromini (ARDS) davolash uchun dori vositalarini ishlab chiqishga qaratilgan. U rejalashtirilmagan homiladorlik va jinsiy yo'l bilan yuqadigan infeksiyalar tarqalishidan ikki tomonlama himoya qilish uchun FC2 ayollar prezervativini taqdim etadi. Kompaniya semirib ketgan va ortiqcha vaznga ega bo'lgan keksa bemorlarda yog' yo'qotishini ko'paytirish va mushak yo'qotishini oldini olish uchun, shuningdek, AR+ ER+ HER2- metastatik ko'krak bezi saratoni uchun davolash maqsadida og'iz orqali qabul qilinadigan selektiv androgen retseptorlari modulyatori bo'lgan enobosarm va virusli o'pka infektsiyasi bo'lgan, virusli ARDS va o'lim xavfi yuqori bo'lgan bemorlarni davolash uchun mikrotubulalar buzuvchi sabizabulinni ishlab chiqadi. Kompaniya ilgari The Female Health Company nomi bilan tanilgan va 2017 yil iyul oyida Veru Inc. nomini o'zgartirgan. Veru Inc. 1971 yilda tashkil etilgan va Mayami, Floridada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Domingo Rodriguez M.D. | Executive Vice President of Global Clinical Operations |
| Dr. Gary Bird Ph.D. | Executive Vice President of Quality & Regulatory Affairs |
| Dr. Harry D. Fisch F.A.C.S., M.D. | Vice Chairman & Chief Corporate Officer |
| Dr. K. Gary Barnette Ph.D. | Chief Scientific Officer |
| Dr. Mitchell S. Steiner F.A.C.S., M.D. | Chairman, President & CEO |
| Mr. Kevin J. Gilbert CPA, J.D. | Executive Vice President of Corporate Development |
| Mr. Martin Tayler | Executive Vice President of FC2 Global Operations |
| Mr. Philip R. Greenberg J.D. | Executive VP, General Counsel & Secretary |
| Mr. Samuel Fisch | Executive Director of Investor Relations & Corporate Communications |
| Ms. Michele Greco CPA | CFO & Chief Administrative Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-13 | 8-K | veru20260312_8k.htm |
| 2026-01-28 | DEFA14A | ny20058671x2_defa14a.htm |
| 2025-12-17 | 8-K | d55858d8k.htm |
| 2025-09-26 | 8-K | veru20250923_8k.htm |
| 2025-08-27 | 8-K | veru20250827_8k.htm |
| 2025-08-12 | 8-K | d59822d8k.htm |
| 2025-07-25 | 8-K | veru20250724c_8k.htm |
| 2025-07-15 | DEFA14A | ef20052032_defa14a.htm |
| 2025-06-10 | DEF 14A | ny20048127x2_def14a.htm |
| 2025-05-09 | PRE 14A | ny20048127x1_pre14a.htm |